| 000 | 01374 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514181320.0 | ||
| 264 | 0 | _c20040628 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.2004.01812.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathus-Vliegen, E M H | |
| 245 | 0 | 0 |
_aLipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cMar 2004 |
||
| 300 |
_a601-11 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aCholecystokinin _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGallbladder _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactones _xtherapeutic use |
| 650 | 0 | 4 |
_aLipase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 | _aOrlistat |
| 650 | 0 | 4 | _aWeight Loss |
| 700 | 1 | _aVan Ierland-Van Leeuwen, M L | |
| 700 | 1 | _aTerpstra, A | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 19 _gno. 5 _gp. 601-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.2004.01812.x _zAvailable from publisher's website |
| 999 |
_c14708416 _d14708416 |
||